Escolar Documentos
Profissional Documentos
Cultura Documentos
Company Profile
Business Summary
Sector
Sintex Industries Ltd. provides plastics and niche textile-related products in India.
>> Plastics
The company operates through two business segments: Plastics and Textile.
The Plastics segment provides solutions in global plastic processing space from creating housing units to small components
that find application in the medical equipment and electrical businesses.
Plastics segment is further divided into two divisions: Building products and Custom moulding.
The Building products division provides products to application in residential, commercial and industrial structures.
The Custom molding division provides SMC products, Industrial containers, Pallets, FRP tanks and Insulated boxes.
The Textile segment specializes in distinctive products, catering to the upper segment of fashion industry.
It also engages in the manufacture of corduroy and structured fabric.
The company has diversified its product range to sophisticated home furnishing and technical textiles.
The company was founded on June 1, 1931 and is headquartered in Kalol, India.
Number of employees : 3 703 persons.
2013
2014
%
Plastics
39,833
89.8%
46,347
91.2%
46,135 79%
Textiles
4,702
10.6%
4,732
9.3%
5,482 9.4%
Unallocated
504.60
1.1%
595.70
1.2%
774.40 1.3%
Infastructure
7,027 12%
India
2013
%
2014
%
INR (in
Million)
33,795
76.2%
38,098
75%
43,088 73.7%
Europe
9,463
21.3%
11,659
23%
15,176
26%
Others
1,782
4%
1,918
3.8%
1,156
2%
07/10/15
10/13/15
01/14/16
01/28/15
08/01/14
07/18/14
Managers
Name
Age
Since
Title
Rahulbhai
Arunbhai Patel,
MBA
56
1993
Amit Dineshbhai
Patel
49
1993
Satyanarayan B.
Dangayach
63
Dineshbhai B.
Patel
81
1972
Laxmiraj M.
Rathod, MBA
Shareholders
Name
Shares
78,103,905
20.1%
20,762,637
5.34%
15,000,000
3.86%
10,980,017
2.82%
7,268,545
1.87%
Disclaimer : Marketscreener.com is a website published by SURPERFORMANCE SAS. Surperformance or Marketscreener.com is not a registered broker-dealer nor
a registered investment adviser. You understand that this web site and its content is furnished for your personal, noncommercial, informational purposes only, and that
no mention of a particular security in this website constitutes a recommendation to buy, sell, or hold any other security, nor that any particular security, portfolio of
securities, transaction or investment strategy is suitable for any specific person. Surperformance and Marketscreener.com services...
http://www.4-traders.com
Page 1 of 6
Financial Ratios
Size
Capitalization
2015e
2016e
51 718 M INR
51 718 M INR
2015e
2016e
9,87x
8,06x
Capitalization / Revenue
0,75x
0,64x
EV / Revenue
EV / EBITDA
0,58%
0,60%
1,09x
1,01x
2015e
13,3% 12,8%
1,62x
Actuals in M INR
2012
2013
2014
2015
2016
2017
44 368
50 794
58 426
69 201
80 185
94 407
5 666
7 695
9 642
11 586
13 647
16 839
5 499
5 641
7 094
9 207
10 288
12 779
4 179
3 871
4 814
6 307
7 678
10 204
Net income
3 068
3 238
3 647
4 932
5 958
7 694
EPS ( INR)
11,3
11,4
11,7
12,3
15,0
18,1
0,65
0,70
0,70
0,70
0,73
0,77
0,54%
0,58%
0,58%
0,58%
0,60%
0,63%
Yield
Announcement Date
05/10/2012
12:52pm
05/07/2013
09:21am
05/08/2014
02:34pm
11,4% 12,0%
Rate of Dividend
5,69% 4,87%
2015e
2016e
21,6%
6,24%
CAPEX / Sales
Estimates in M INR
0,74x
7,13% 7,43%
2016e
Revenue Revisions
EPS Revisions
Disclaimer : 4-traders.com is a website published by SURPERFORMANCE SAS. Surperformance or 4-traders.com is not a registered broker-dealer nor a registered
investment adviser. You understand that this web site and its content is furnished for your personal, noncommercial, informational purposes only, and that no mention
of a particular security in this website constitutes a recommendation to buy, sell, or hold any other security, nor that any particular security, portfolio of securities,
transaction or investment strategy is suitable for any specific person.
http://www.4-traders.com
Page 2 of 6
Analysts' Consensus
Consensus
Sell
Mean consensus
Buy
OUTPERFORM
Number of Analysts
139 INR
121 INR
38%
14%
-1,1%
Consensus detail
Disclaimer : 4-traders.com is a website published by SURPERFORMANCE SAS. Surperformance or 4-traders.com is not a registered broker-dealer nor a registered
investment adviser. You understand that this web site and its content is furnished for your personal, noncommercial, informational purposes only, and that no mention
of a particular security in this website constitutes a recommendation to buy, sell, or hold any other security, nor that any particular security, portfolio of securities,
transaction or investment strategy is suitable for any specific person.
http://www.4-traders.com
Page 3 of 6
Chart Sector
Subsector Plastics
1st jan.
Capitalisation (M$)
26.75%
827
AIR LIQUIDE
18.86%
44 470
15.14%
43 454
LINDE AG
25.13%
37 751
PRAXAIR, INC.
-5.56%
34 985
5.33%
32 265
-0.71%
31 315
-2.25%
27 932
SHERWIN-WILLIAMS CO
10.50%
27 551
AKZO NOBEL
29.77%
19 120
--.--%
18 147
-1.23%
16 708
LG CHEM LTD
--.--%
16 445
--.--%
15 829
--.--%
14 068
3.91%
13 425
0.00%
13 228
NOVOZYMES A/S
30.16%
12 502
SOLVAY
24.29%
12 465
--.--%
12 312
24.10%
11 486
Growth (Revenue)
Profitability
Finances
Valuation
PER
Disclaimer : 4-traders.com is a website published by SURPERFORMANCE SAS. Surperformance or 4-traders.com is not a registered broker-dealer nor a registered
investment adviser. You understand that this web site and its content is furnished for your personal, noncommercial, informational purposes only, and that no mention
of a particular security in this website constitutes a recommendation to buy, sell, or hold any other security, nor that any particular security, portfolio of securities,
transaction or investment strategy is suitable for any specific person.
http://www.4-traders.com
Page 4 of 6
Technical Analysis
Daily chart
Mid-Term
Long Term
Neutral
Bullish
Bullish
133
133
126
Spread/Res.
-8,8%
-8,8%
-3,8%
Spread/Supp.
7,5%
24%
27%
113
98,1
95,6
Trend
Resistance
Support
Indicators
STIM
RSI 14 days
MA20
MA50
MA100
MA20 / Price
MA50 / Price
MA100 / Price
53.27
122.13
115.37
105.76
-0.68%
4.89%
12.81%
Volumes
Session volume
Avg. Volume 20 sessions
Volume ratio
Session exchange
Avg. Exchange 20 sessions
Number of securities
Swapped fund session
5 334 736
3 962 520
1.35
647 103 477INR
480 653 676INR
414 071 915
1.29%
Weekly chart
-0.57%
+26.75%
+163.12%
+415.29%
Extremes
10-year High (11/12/2010)
10-year Low (09/04/2013)
Disclaimer : 4-traders.com is a website published by SURPERFORMANCE SAS. Surperformance or 4-traders.com is not a registered broker-dealer nor a registered
investment adviser. You understand that this web site and its content is furnished for your personal, noncommercial, informational purposes only, and that no mention
of a particular security in this website constitutes a recommendation to buy, sell, or hold any other security, nor that any particular security, portfolio of securities,
transaction or investment strategy is suitable for any specific person.
237
16.8
http://www.4-traders.com
Page 5 of 6
Summary
Strengths
Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in
the coming years.
Historically, the company has been releasing figures that are above expectations.
Trading Rating
Investor Rating
Growth (Revenue)
Its low valuation, with P/E ratio at 9.87 and 8.06 for the ongoing fiscal year and 2016 respectively,
makes the stock pretty attractive with regard to earnings multiples.
Analysts have consistently raised their revenue expectations for the company, which provides
good prospects for the current and next years in terms of revenue growth.
Weaknesses
Business Predictability
PER
Potential
Yield
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or
purchasing the stock.
The company has strong fundamentals. More than 70% of listed companies have a lower mix of
growth, profitability, debt and visibility criteria.
Finances
Earnings quality
For the past year, analysts covering the stock have been revising their EPS expectations upwards
in a significant manner.
The difference between current prices and the average target price is rather important and implies
a significant appreciation potential for the stock.
Profitability
Over the last twelve months, the sales forecast has been frequently revised upwards.
For several months, analysts have been revising their EPS estimates roughly upwards.
Valuation
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
The company is not the most generous with respect to shareholders' compensation.
Stock prices approach a strong long-term resistance in weekly data at INR 126.1.
Disclaimer : 4-traders.com is a website published by SURPERFORMANCE SAS. Surperformance or 4-traders.com is not a registered broker-dealer nor a registered
investment adviser. You understand that this web site and its content is furnished for your personal, noncommercial, informational purposes only, and that no mention
of a particular security in this website constitutes a recommendation to buy, sell, or hold any other security, nor that any particular security, portfolio of securities,
transaction or investment strategy is suitable for any specific person.
http://www.4-traders.com
Page 6 of 6